These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25825466)

  • 1. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
    Galduróz JC; Ramos AC; Santos-Galduróz RF
    Neurology; 2015 Mar; 84(13):1386-7. PubMed ID: 25825466
    [No Abstract]   [Full Text] [Related]  

  • 2. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
    Liang JW; Shanker VL; Groves M
    Neurology; 2015 Mar; 84(13):1386-7. PubMed ID: 25992401
    [No Abstract]   [Full Text] [Related]  

  • 3. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
    Weintraub D; Papay K; Xie SX
    Neurology; 2015 Mar; 84(13):1386-7. PubMed ID: 25992402
    [No Abstract]   [Full Text] [Related]  

  • 4. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
    Papay K; Xie SX; Stern M; Hurtig H; Siderowf A; Duda JE; Minger J; Weintraub D
    Neurology; 2014 Aug; 83(9):826-33. PubMed ID: 25037206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone for High-Dose Venlafaxine-Associated Kleptomania.
    Mouaffak F
    J Clin Psychopharmacol; 2020; 40(3):315-316. PubMed ID: 32332474
    [No Abstract]   [Full Text] [Related]  

  • 6. Adolescent kleptomania treated with naltrexone--a case report.
    Grant JE; Kim SW
    Eur Child Adolesc Psychiatry; 2002 Apr; 11(2):92-5. PubMed ID: 12033750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of kleptomania and compulsive sexual behavior treated with naltrexone.
    Grant JE; Kim SW
    Ann Clin Psychiatry; 2001 Dec; 13(4):229-31. PubMed ID: 11958364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological treatment of kleptomania--review].
    Kozian R; Otto FG
    Psychiatr Prax; 2003 May; 30(4):216-20. PubMed ID: 12768528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
    Grant JE; Kim SW; Hartman BK
    J Clin Psychiatry; 2008 May; 69(5):783-9. PubMed ID: 18384246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.
    Kim SW; Grant JE; Adson DE; Shin YC
    Biol Psychiatry; 2001 Jun; 49(11):914-21. PubMed ID: 11377409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypersexuality and other impulse control disorders in Parkinson's disease].
    Nelis EA; Berendse HW; van den Heuvel OA
    Ned Tijdschr Geneeskd; 2016; 160():A9359. PubMed ID: 26732226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kleptomania treated with naltrexone in a patient with intellectual disability.
    Mouaffak F; Hamzaoui S; Kebir O; Laqueille X
    J Psychiatry Neurosci; 2020 Jan; 45(1):71-72. PubMed ID: 31845772
    [No Abstract]   [Full Text] [Related]  

  • 13. An open-label study of naltrexone in the treatment of kleptomania.
    Grant JE; Kim SW
    J Clin Psychiatry; 2002 Apr; 63(4):349-56. PubMed ID: 12000210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid antagonists in broadly defined behavioral addictions: a narrative review.
    Piquet-Pessôa M; Fontenelle LF
    Expert Opin Pharmacother; 2016; 17(6):835-44. PubMed ID: 26798982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of high-dose naltrexone treatment: hepatic transaminase profiles among outpatients.
    Kim SW; Grant JE; Yoon G; Williams KA; Remmel RP
    Clin Neuropharmacol; 2006; 29(2):77-9. PubMed ID: 16614539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
    Grant JE; Potenza MN; Hollander E; Cunningham-Williams R; Nurminen T; Smits G; Kallio A
    Am J Psychiatry; 2006 Feb; 163(2):303-12. PubMed ID: 16449486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure and response prevention therapy augmented with naltrexone in kleptomania: a controlled case study using galvanic skin response for monitoring.
    Olbrich S; Jahn I; Stengler K
    Behav Cogn Psychother; 2019 Sep; 47(5):622-627. PubMed ID: 30894239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid antagonists in the treatment of impulse-control disorders.
    Kim SW
    J Clin Psychiatry; 1998 Apr; 59(4):159-64. PubMed ID: 9590665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impulse control disorders: clinical characteristics and pharmacological management.
    Grant JE; Potenza MN
    Ann Clin Psychiatry; 2004; 16(1):27-34. PubMed ID: 15147110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroscience in gambling policy and treatment: an interdisciplinary perspective.
    Yücel M; Carter A; Allen AR; Balleine B; Clark L; Dowling NA; Gainsbury SM; Goudriaan AE; Grant J; Hayes A; Hodgins D; van Holst R; Lattimore R; Livingstone C; Lorenzetti V; Lubman D; Murawski C; Parkes L; Petry N; Room R; Singh B; Thomas A; Townshend P; Youssef G; Hall W
    Lancet Psychiatry; 2017 Jun; 4(6):501-506. PubMed ID: 28219609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.